A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults With Neurofibromatosis Type 1 A Phase II Trial of Poly-ICLCfor Progressive, Previously Treated Low-Grade Gliomas in Children and Y ...
NF1;Low-grade Glioma
Drug: PolyICLC
University of Alabama at Birmingham
Children's Healthcare of Atlanta;Children's Hospital Los Angeles